CEA-Tricom: Began Phase I study

Therion Biologics Corp., Cambridge, Mass. Product: CEA-Tricom Business: Cancer Therapeutic category: Immune stimulation Target: T cells Description: Recombinant pox virus-based vaccine targeting carc...